In the post-menopause cohort, CEA and tumor diameter, which comprise the R2 predictive index, did not reach significant differentiation; on the other hand, CA125, comprising the CPH index and the ROMA index, in the pre-menopause cohort did not reach significant differentiation. The gene discussed is CEACAM5; the disease is neoplasm.